With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Application of Epigenetic Markers for Early Detection of Childhood Leukemia.||University of California San Francisco / Sheng Zhong||Epidemiology Grants||2008||California|
|Understanding the Role of Translational Control in Humanized Mouse Models for Medulloblastoma||University of California San Francisco / Ozlem Aksoy, PhD||Young Investigator Grants||2015||California|
|Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome||University of California San Francisco / Adam de Smith, Ph.D.||'A' Award Grants||2014||California|
|Chemical Genetics and CRISPRi/a Screen for Novel Therapeutic Targets in a Humanized Model for MYCN Associated High-Risk Pediatric Neuroblastoma||University of California San Francisco / Zhenyi An, PhD||Young Investigator Grants||2015||California|
|Targeting eEF2 Kinase in Neuroblastoma||University of California San Francisco / William Weiss, M.D., Ph.D.||Innovation Grants||2014||California|
|Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia||University of California San Francisco / Mignon Loh, M.D.||Innovation Grants||2014||California|
|A comprehensive public resource for fusion-negative sarcoma sequencing data||University of California San Francisco / Alejandro Sweet-Cordero, MD & Richard Gorlick, MD||Crazy 8 Initiative||2019||California|
|Characterization of the Role of Chromosome 1p Deletion in MYCN-Amplified Neuroblastoma||University of California San Francisco / Miller Huang, PhD||Young Investigator Grants||2013||California|
|Alternative Splicing Driven by MYCN Activates RAS-MAPK in Neuroblastoma||University of California San Francisco / William Weiss, MD/PhD||Innovation Grants||2018||California|
|Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma||University of California San Francisco / William Clay Gustafson, MD, PhD||'A' Award Grants||2011||California|